Miguel Farolan, MD | |
801 S Washington Street, Edward Hospital, Naperville, IL 60566-7060 | |
(630) 355-0450 | |
(630) 527-3911 |
Full Name | Miguel Farolan |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 39 Years |
Location | 801 S Washington Street, Naperville, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821176850 | NPI | - | NPPES |
0360788342 | Medicaid | IL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZC0500X | Pathology - Cytopathology | (Illinois) | Primary |
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Edward Hospital | Naperville, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Associated Pathologists And Laboratory Physicians Llc | 0446582175 | 12 |
Dupage Medical Group Ltd | 5496667941 | 1209 |
Laboratory And Pathology Diagnostics Llc | 4486630886 | 13 |
News Archive
Researchers from the Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) were recently awarded a $3.5 million grant from the National Institute on Drug Abuse (NIDA), to improve upon the "seek, test, treat, and retain" paradigm in Eastern Europe among HIV-infected Russian and Eastern European injection drug users (IDUs) in narcology care.
A drug already approved for people with cancer shows early potential as a therapy for a common form of dementia, UT Southwestern Medical Center researchers report.
The Senate Finance Committee is meeting beginning today to consider chairman Max Baucus' health proposal and is very likely to make substantial changes.
A new study shows that a test of biomarkers for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma.
› Verified 1 days ago
Entity Name | Dupage Medical Group Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
Researchers from the Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) were recently awarded a $3.5 million grant from the National Institute on Drug Abuse (NIDA), to improve upon the "seek, test, treat, and retain" paradigm in Eastern Europe among HIV-infected Russian and Eastern European injection drug users (IDUs) in narcology care.
A drug already approved for people with cancer shows early potential as a therapy for a common form of dementia, UT Southwestern Medical Center researchers report.
The Senate Finance Committee is meeting beginning today to consider chairman Max Baucus' health proposal and is very likely to make substantial changes.
A new study shows that a test of biomarkers for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma.
› Verified 1 days ago
Entity Name | Laboratory & Pathology Diagnostics Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285713826 PECOS PAC ID: 4486630886 Enrollment ID: O20040626000144 |
News Archive
Researchers from the Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) were recently awarded a $3.5 million grant from the National Institute on Drug Abuse (NIDA), to improve upon the "seek, test, treat, and retain" paradigm in Eastern Europe among HIV-infected Russian and Eastern European injection drug users (IDUs) in narcology care.
A drug already approved for people with cancer shows early potential as a therapy for a common form of dementia, UT Southwestern Medical Center researchers report.
The Senate Finance Committee is meeting beginning today to consider chairman Max Baucus' health proposal and is very likely to make substantial changes.
A new study shows that a test of biomarkers for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma.
› Verified 1 days ago
Entity Name | Associated Pathologists And Laboratory Physicians Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568903565 PECOS PAC ID: 0446582175 Enrollment ID: O20191030002562 |
News Archive
Researchers from the Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) were recently awarded a $3.5 million grant from the National Institute on Drug Abuse (NIDA), to improve upon the "seek, test, treat, and retain" paradigm in Eastern Europe among HIV-infected Russian and Eastern European injection drug users (IDUs) in narcology care.
A drug already approved for people with cancer shows early potential as a therapy for a common form of dementia, UT Southwestern Medical Center researchers report.
The Senate Finance Committee is meeting beginning today to consider chairman Max Baucus' health proposal and is very likely to make substantial changes.
A new study shows that a test of biomarkers for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Miguel Farolan, MD Department 4387, Carol Stream, IL 60122-4387 Ph: (630) 355-0450 | Miguel Farolan, MD 801 S Washington Street, Edward Hospital, Naperville, IL 60566-7060 Ph: (630) 355-0450 |
News Archive
Researchers from the Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) were recently awarded a $3.5 million grant from the National Institute on Drug Abuse (NIDA), to improve upon the "seek, test, treat, and retain" paradigm in Eastern Europe among HIV-infected Russian and Eastern European injection drug users (IDUs) in narcology care.
A drug already approved for people with cancer shows early potential as a therapy for a common form of dementia, UT Southwestern Medical Center researchers report.
The Senate Finance Committee is meeting beginning today to consider chairman Max Baucus' health proposal and is very likely to make substantial changes.
A new study shows that a test of biomarkers for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma.
› Verified 1 days ago
Dr. Karl Michael Napekoski, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S. Washington Street, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Sarah B Clark, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Richard R Anderson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Theodore E Troe, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Cathryn A Goldberg, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Rohit Gupta, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Dwight W Morrow, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 |